Area of research
Materials Chemistry · Biomedical Engineering
Research interest
Research interests include Nanoplatforms for cancer theranostics, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, and Metal complexes synthesis and properties.
Light-Activated Metal-Dependent Protein Degradation: A Heterobifunctional Ruthenium(II) Photosensitizer Targeting New Delhi Metallo-β-lactamase 1
Recent Advances in Metal Complexes for Antimicrobial Photodynamic Therapy
Recent advances in ruthenium(II) and iridium(III) complexes containing nanosystems for cancer treatment and bioimaging
Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia
An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer
A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy
A Mitochondrion‐Localized Two‐Photon Photosensitizer Generating Carbon Radicals Against Hypoxic Tumors
Oxygen self-sufficient photodynamic therapy
An Ultrasmall RuO<sub>2</sub> Nanozyme Exhibiting Multienzyme-like Activity for the Prevention of Acute Kidney Injury
Rational Design of Cyclometalated Iridium(III) Complexes for Three‐Photon Phosphorescence Bioimaging
Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II
Lysosome-Targeting Iridium(III) Probe with Near-Infrared Emission for the Visualization of NO/O<sub>2</sub><sup>•-</sup> Crosstalk via In Vivo Peroxynitrite Imaging
An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer
A self-assembled Ru–Pt metallacage as a lysosome-targeting photosensitizer for 2-photon photodynamic therapy
FerriIridium: A Lysosome‐Targeting Iron(III)‐Activated Iridium(III) Prodrug for Chemotherapy in Gastric Cancer Cells
Recent advances in lysosome-targeting luminescent transition metal complexes
A mitochondria-targeting dinuclear Ir–Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells
Metal complexes for mitochondrial bioimaging
Harnessing ruthenium(II) as photodynamic agents: Encouraging advances in cancer therapy
Heterometallic Ru–Pt metallacycle for two-photon photodynamic therapy
Oncosis-inducing cyclometalated iridium(<scp>iii</scp>) complexes
A mitochondria-targeting hetero-binuclear Ir(<scp>iii</scp>)–Pt(<scp>ii</scp>) complex induces necrosis in cisplatin-resistant tumor cells
Organelle-targeting metal complexes: From molecular design to bio-applications